Argus R_EH1_T_AH0_N_AH0_L P_R_AO2_S_TH_EH1_S_IH0_S    AO1_L_S_OW0 N_OW1_N AE1_Z AH0 bionic AY1    IH1_Z AE1_N IH2_L_EH2_K_T_R_AA1_N_IH0_K R_EH1_T_AH0_N_AH0_L IH2_M_P_L_AE1_N_T M_AE2_N_Y_AH0_F_AE1_K_CH_ER0_D B_AY1 DH_AH0 American K_AH1_M_P_AH0_N_IY2 Second Sight Medical Products It IH1_Z Y_UW1_Z_D AE1_Z AH0 V_IH1_ZH_AH0_W_AH0_L P_R_AO2_S_TH_EH1_S_IH0_S T_UW1 IH2_M_P_R_UW1_V DH_AH0 V_IH1_ZH_AH0_N AH1_V P_IY1_P_AH0_L W_IH1_DH S_AH0_V_IH1_R K_EY1_S_AH0_Z AH1_V retinitis pigmentosa The Argus II V_ER1_ZH_AH0_N AH1_V DH_AH0 S_IH1_S_T_AH0_M W_AA1_Z AH0_P_R_UW1_V_D F_AO1_R M_AA1_R_K_AH0_T_IH0_NG IH0_N DH_AH0 European Union IH0_N March 2011    AH0_N_D IH1_T R_AH0_S_IY1_V_D AH0_P_R_UW1_V_AH0_L IH0_N DH_AH0 US IH0_N February 2013 AH1_N_D_ER0 AH0 HH_Y_UW2_M_AE2_N_AH0_T_EH1_R_IY0_AH0_N D_IH0_V_AY1_S IH0_G_Z_EH1_M_P_SH_AH0_N    The Argus II S_IH1_S_T_AH0_M K_AA1_S_T_S AH0_B_AW1_T US 150 000    IH0_K_S_K_L_UW1_D_IH0_NG DH_AH0 K_AA1_S_T AH1_V DH_AH0 IH2_M_P_L_AE0_N_T_EY1_SH_AH0_N S_ER1_JH_ER0_IY0 AH0_N_D T_R_EY1_N_IH0_NG T_UW1 L_ER1_N T_UW1 Y_UW1_S DH_AH0 D_IH0_V_AY1_S The Argus II IH1_Z S_P_AH0_S_IH1_F_IH0_K_L_IY0 D_IH0_Z_AY1_N_D T_UW1 T_R_IY1_T P_IY1_P_AH0_L W_IH1_DH retinitis pigmentosa    The D_IH0_V_AY1_S W_AA1_Z AH0_P_R_UW1_V_D W_IH1_DH D_EY1_T_AH0 F_R_AH1_M AH0 S_IH1_NG_G_AH0_L AA1_R_M K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L DH_AE1_T EH0_N_R_OW1_L_D TH_ER1_D_IY2 P_IY1_P_AH0_L W_IH1_DH S_AH0_V_IH1_R retinitis pigmentosa ;  DH_AH0 L_AO1_NG_G_AH0_S_T F_AA1_L_OW0 AH1_P AA1_N AH0 T_R_AY1_AH0_L S_AH0_B_JH_EH1_K_T W_AA1_Z 38 M_AH1_N_TH_S    People IH0_N DH_AH0 T_R_AY1_AH0_L R_AH0_S_IY1_V_D DH_AH0 IH2_M_P_L_AE1_N_T IH0_N OW1_N_L_IY0 W_AH1_N AY1 AH0_N_D T_EH1_S_T_S W_ER1 K_AH0_N_D_AH1_K_T_AH0_D W_IH1_DH DH_AH0 D_IH0_V_AY1_S S_W_IH1_CH_T AA1_N    AO1_R S_W_IH1_CH_T AO1_F AE1_Z AH0 K_AH0_N_T_R_OW1_L    With DH_AH0 D_IH0_V_AY1_S S_W_IH1_CH_T AA1_N    AH0_B_AW1_T 23 %  AH1_V DH_AH0 S_AH1_B_JH_IH0_K_T_S HH_AE1_D IH2_M_P_R_UW1_V_M_AH0_N_T_S IH0_N DH_EH1_R AH0_B_IH1_L_AH0_T_IY2 T_UW1 S_IY1 ;  AO1_L HH_AE1_D B_IH1_N AE1_T AO1_R HH_AY1_ER0 AA1_N DH_AH0 LogMAR S_K_EY1_L AH0_N_D IH2_M_P_R_UW1_V_M_AH0_N_T_S R_EY1_N_JH_D F_R_AH1_M JH_AH1_S_T AH1_N_D_ER0 T_UW1 LogMAR  â€“  DH_AH0 IH0_K_W_IH1_V_AH0_L_AH0_N_T AH1_V 20 1262 R_IY1_D_IH0_NG AH0_B_IH1_L_AH0_T_IY2     18 96 %  AH1_V DH_AH0 S_AH1_B_JH_IH0_K_T_S W_ER1 B_EH1_T_ER0 EY1_B_AH0_L T_UW1 AY0_D_EH1_N_T_AH0_F_AY2 AH0 W_AY1_T S_K_W_EH1_R AA1_N AH0 B_L_AE1_K K_AH0_M_P_Y_UW1_T_ER0 S_K_R_IY1_N ;  57 %  W_ER1 M_AO1_R EY1_B_AH0_L T_UW1 D_AH0_T_ER1_M_AH0_N DH_AH0 D_ER0_EH1_K_SH_AH0_N IH0_N W_IH1_CH AH0 W_AY1_T B_AA1_R M_UW1_V_D AH0_K_R_AO1_S AH0 B_L_AE1_K K_AH0_M_P_Y_UW1_T_ER0 S_K_R_IY1_N With DH_AH0 D_IH0_V_AY1_S S_W_IH1_CH_T AA1_N    AH0_B_AW1_T 60 %  W_ER1 EY1_B_AH0_L T_UW1 AE1_K_Y_ER0_AH0_T_L_IY0 W_AO1_K T_UW1 AH0 D_AO1_R DH_AE1_T W_AA1_Z 20 F_IY1_T AH0_W_EY1    AE1_Z AH0_P_OW1_Z_D T_UW1 OW1_N_L_IY0 %  W_IH1_DH DH_AH0 D_IH0_V_AY1_S S_W_IH1_CH_T AO1_F ;  93 %  HH_AE1_D N_OW1 CH_EY1_N_JH IH0_N DH_EH1_R P_ER0_S_EH1_P_SH_AH0_N AH1_V L_AY1_T    18 Among DH_AH0 TH_ER1_D_IY2 S_AH1_B_JH_IH0_K_T_S IH0_N DH_AH0 K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L    DH_EH1_R W_ER1 N_AY1_N S_IH1_R_IY0_AH0_S AE0_D_V_ER1_S IH0_V_EH1_N_T_S R_AH0_K_AO1_R_D_AH0_D    IH2_N_K_L_UW1_D_IH0_NG L_OW1_ER0 DH_AE1_N N_AO1_R_M_AH0_L IH2_N_T_R_AH0_OW1_K_Y_UW0_L_ER0 P_R_EH1_SH_ER0    IH0_R_OW1_ZH_AH0_N AH1_V DH_AH0 K_AA2_N_JH_AH0_NG_K_T_AY1_V_AH0    R_IY0_OW1_P_AH0_N_IH0_NG AH1_V DH_AH0 S_ER1_JH_IH0_K_AH0_L W_AW1_N_D    IH2_N_F_L_AH0_M_EY1_SH_AH0_N IH2_N_S_AY1_D DH_AH0 AY1    AH0_N_D R_EH1_T_AH0_N_AH0_L detachments     19    There IH1_Z AO1_L_S_OW0 AH0 R_IH1_S_K AH1_V B_AE0_K_T_IH1_R_IY0_AH0_L IH2_N_F_EH1_K_SH_AH0_N F_R_AH1_M DH_AH0 IH2_M_P_L_AE1_N_T_IH0_D K_EY1_B_AH0_L_Z DH_AE1_T K_AH0_N_EH1_K_T DH_AH0 IH2_M_P_L_AE1_N_T T_UW1 DH_AH0 S_IH1_G_N_AH0_L P_R_AA1_S_EH2_S_ER0    The IH2_M_P_L_AE0_N_T_EY1_SH_AH0_N P_R_AH0_S_IY1_JH_ER0 T_EY1_K_S S_EH1_V_ER0_AH0_L AW1_ER0_Z    W_IH1_DH DH_AH0 P_ER1_S_AH0_N R_AH0_S_IY1_V_IH0_NG DH_AH0 IH2_M_P_L_AE1_N_T AH1_N_D_ER0 JH_EH1_N_ER0_AH0_L AE2_N_IH0_S_TH_IY1_ZH_IY2_AH0 The S_ER1_JH_AH0_N R_IY0_M_UW1_V_Z DH_AH0 V_IH1_T_R_IY0_AH0_S HH_Y_UW1_M_ER0 AH0_N_D EH1_N_IY0 M_EH1_M_B_R_EY2_N_Z AA1_N DH_AH0 R_EH1_T_AH0_N_AH0 W_EH1_R DH_AH0 IH2_M_P_L_AE1_N_T W_IH1_L B_IY1 P_L_EY1_S_T The IH2_M_P_L_AE1_N_T IH1_Z AH0_T_AE1_CH_T T_UW1 DH_AH0 S_ER1_F_AH0_S AH1_V DH_AH0 R_EH1_T_AH0_N_AH0 W_IH1_DH AH0 T_AE1_K The K_EY1_B_AH0_L_Z K_AH0_N_EH1_K_T_IH0_NG DH_AH0 IH2_M_P_L_AE1_N_T T_UW1 DH_AH0 P_R_AA1_S_EH2_S_ER0 AA1_R R_AH1_N TH_R_UW1 DH_AH0 P_AA1_R_Z plana    AH0 R_IY1_JH_AH0_N N_IH1_R W_EH1_R DH_AH0 AY1_R_AH0_S AH0_N_D sclera T_AH1_CH    The Argus IH2_M_P_L_AE1_N_T EH1_S P_R_AY1_M_EH2_R_IY0 IH0_K_S_T_ER1_N_AH0_L EH1_L_AH0_M_AH0_N_T IH1_Z AH0 D_IH1_JH_AH0_T_AH0_L K_AE1_M_ER0_AH0 M_AW1_N_T_AH0_D AA1_N AY1_G_L_AE2_S F_R_EY1_M_Z    W_IH1_CH AH0_B_T_EY1_N_Z IH1_M_AH0_JH_AH0_Z AH1_V DH_AH0 Y_UW1_Z_ER0 EH1_S S_ER0_AW1_N_D_IH0_NG_Z ;  S_IH1_G_N_AH0_L_Z F_R_AH1_M DH_AH0 K_AE1_M_ER0_AH0 AA1_R T_R_AE0_N_S_M_IH1_T_IH0_D wirelessly T_UW1 AH0 computerised IH1_M_AH0_JH P_R_AA1_S_EH2_S_ER0 The P_R_AA1_S_EH2_S_ER0 IH1_Z IH0_N T_ER1_N K_AH0_N_EH1_K_T_IH0_D B_AY1 K_EY1_B_AH0_L_Z T_UW1 DH_AH0 IH2_M_P_L_AE1_N_T IH2_T_S_EH1_L_F    W_IH1_CH IH1_Z S_ER1_JH_IH0_K_AH0_L_IY0 IH2_M_P_L_AE1_N_T_IH0_D AA1_N DH_AH0 S_ER1_F_AH0_S AH1_V DH_AH0 P_ER1_S_AH0_N EH1_S R_EH1_T_AH0_N_AH0 AH0_N_D T_AE1_K_T IH1_N_T_UW0 P_L_EY1_S The IH2_M_P_L_AE1_N_T K_AH0_N_S_IH1_S_T_S AH1_V 60 IH2_L_EH1_K_T_R_OW0_D_Z    IY1_CH 200 M_AY1_K_R_AA2_N_Z IH0_N D_AY0_AE1_M_AH0_T_ER0     The IH2_M_P_L_AE1_N_T EH1_S M_AE2_N_Y_AH0_F_AE1_K_CH_ER0_ER0    Second Sight Medical Products    W_AA1_Z F_AW1_N_D_IH0_D IH0_N Sylmar    California    IH0_N 1998    B_AY1 Alfred Mann    Samuel Williams    AH0_N_D Gunnar Bjorg    Williams    AE1_N IH2_N_V_EH1_S_T_ER0 IH0_N AH0 K_AA1_K_L_IY0_ER0 IH2_M_P_L_AE1_N_T K_AH1_M_P_AH0_N_IY2 AA1_P_ER0_EY2_T_AH0_D B_AY1 Mann    AH0_P_R_OW1_CH_T Mann AH0_B_AW1_T F_AW1_N_D_IH0_NG AH0 K_AH1_M_P_AH0_N_IY2 T_UW1 D_IH0_V_EH1_L_AH0_P AH0 S_IH1_M_AH0_L_ER0 P_R_AA1_D_AH0_K_T F_AO1_R DH_AH0 AY1    AH0_N_D Mann K_AO1_L_D AH0 M_IY1_T_IH0_NG W_IH1_DH DH_AH0 T_UW1 AH1_V DH_EH1_M AH0_N_D Robert Greenberg    HH_UW1 W_ER1_K_T AE1_T Mann EH1_S F_AW0_N_D_EY1_SH_AH0_N    Greenberg HH_AE1_D P_R_IY1_V_IY0_AH0_S_L_IY0 W_ER1_K_T AA1_N R_EH1_T_AH0_N_AH0_L P_R_AA0_S_TH_EH1_T_IH0_K_S AE1_Z AH0 G_R_AE1_JH_AH0_W_AH0_T S_T_UW1_D_AH0_N_T AE1_T Johns Hopkins University    AH0_N_D W_AA1_Z AH0_P_OY1_N_T_AH0_D AE1_Z CEO AH1_V DH_AH0 N_UW1 K_AH1_M_P_AH0_N_IY2 W_EH1_N IH1_T W_AA1_Z L_AO1_N_CH_T    The F_ER1_S_T V_ER1_ZH_AH0_N AH1_V DH_AH0 P_R_AO2_S_TH_EH1_S_IH0_S    DH_AH0 Argus    W_AA1_Z K_L_IH1_N_IH0_K_AH0_L_IY0 T_EH1_S_T_IH0_D AA1_N S_IH1_K_S P_IY1_P_AH0_L S_T_AA1_R_T_IH0_NG IH0_N 2002    The S_EH1_K_AH0_N_D V_ER1_ZH_AH0_N    DH_AH0 Argus II    W_AA1_Z D_IH0_Z_AY1_N_D T_UW1 B_IY1 S_M_AO1_L_ER0 AH0_N_D IY1_Z_IY0_ER0 T_UW1 IH2_M_P_L_AE1_N_T    AH0_N_D W_AA1_Z K_OW1 IH2_N_V_EH1_N_T_AH0_D B_AY1 Mark Humayun AH1_V DH_AH0 USC Eye Institute    HH_UW1 HH_AE1_D B_IH1_N IH2_N_V_AA1_L_V_D IH0_N DH_AH0 K_L_IH1_N_AH0_K_AH0_L T_EH1_S_T_IH0_NG AH1_V DH_AH0 Argus     The Argus II W_AA1_Z F_ER1_S_T T_EH1_S_T_IH0_D IH0_N Mexico IH0_N 2006    AH0_N_D DH_EH1_N AH0 30 P_ER1_S_AH0_N K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L W_AA1_Z K_AH0_N_D_AH1_K_T_AH0_D IH0_N 10 M_EH1_D_AH0_K_AH0_L S_EH1_N_T_ER0_Z AH0_K_R_AO1_S Europe AH0_N_D DH_AH0 United States     The Argus II R_AH0_S_IY1_V_D AH0_P_R_UW1_V_AH0_L F_AO1_R K_AH0_M_ER1_SH_AH0_L Y_UW1_S IH0_N DH_AH0 European Union IH0_N March 2011     In February 2013    DH_AH0 FDA AH0_P_R_UW1_V_D DH_AH0 Argus II AH1_N_D_ER0 AH0 HH_Y_UW2_M_AE2_N_AH0_T_EH1_R_IY0_AH0_N D_IH0_V_AY1_S IH0_G_Z_EH1_M_P_SH_AH0_N    AO1_TH_ER0_AY2_Z_IH0_NG IH1_T_S Y_UW1_S F_AO1_R AH1_P T_UW1 000 P_IY1_P_AH0_L IH0_N DH_AH0 US P_ER1 Y_IH1_R      The Argus II W_AA1_Z IH2_N_IH1_SH_AH0_L_IY0 AH0_V_EY1_L_AH0_B_AH0_L AE1_T AH0 L_IH1_M_AH0_T_AH0_D N_AH1_M_B_ER0 AH1_V K_L_IH1_N_IH0_K_S IH0_N France    Germany    Italy    DH_AH0 Netherlands    DH_AH0 United Kingdom AH0_N_D Saudi Arabia    AE1_T AE1_N EU M_AA1_R_K_AH0_T P_R_AY1_S AH1_V US 115 000    When DH_AH0 Argus II L_AO1_N_CH_T IH0_N DH_AH0 United States IH0_N February 2013    Second Sight AH0_N_AW1_N_S_T DH_AE1_T IH1_T W_UH1_D B_IY1 P_R_AY1_S_T AE1_T ER0_AW1_N_D  $ 150 000    IH0_K_S_K_L_UW1_D_IH0_NG DH_AH0 K_AA1_S_T AH1_V S_ER1_JH_ER0_IY0 AH0_N_D Y_UW1_S_AH0_JH T_R_EY1_N_IH0_NG    In August 2013    Second Sight AH0_N_AW1_N_S_T DH_AE1_T R_IY2_IH0_M_B_ER1_S_M_AH0_N_T P_EY1_M_AH0_N_T_S HH_AE1_D B_IH1_N AH0_P_R_UW1_V_D F_AO1_R DH_AH0 Argus II F_AO1_R B_L_AY1_N_D Medicare R_IH0_S_IH1_P_IY0_AH0_N_T_S IH0_N DH_AH0 United States    T_R_AY1_AH0_L IH0_N England F_AH1_N_D_AH0_D B_AY1 NHS England F_AO1_R T_EH1_N P_EY1_SH_AH0_N_T_S B_IH0_G_AE1_N IH0_N 2017   